These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 1634144)

  • 21. Induction of apoptosis by taxol and cisplatin and effect on cell cycle-related proteins in cisplatin-sensitive and -resistant human ovarian cells.
    Zaffaroni N; Silvestrini R; Orlandi L; Bearzatto A; Gornati D; Villa R
    Br J Cancer; 1998 May; 77(9):1378-85. PubMed ID: 9652752
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective potentiation of platinum drug cytotoxicity in cisplatin-sensitive and -resistant human ovarian carcinoma cell lines by amphotericin B.
    Sharp SY; Mistry P; Valenti MR; Bryant AP; Kelland LR
    Cancer Chemother Pharmacol; 1994; 35(2):137-43. PubMed ID: 7987990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bisdioxopiperazine, (+)-1,2-bis(3,5-dioxopiperazinyl-1-yl)propane (ICRF 187), enhances the antiproliferative effect of cisplatin on human ovarian cancer cells.
    Scambia G; Della Bitta R; Benedetti Panici P; De Vincenzo R; Contu G; Ercoli A; Bonanno G; Pierelli L; Mancuso S
    Gynecol Oncol; 1995 Apr; 57(1):16-22. PubMed ID: 7705696
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trifluoperazine stimulates ionizing radiation induced cell killing through inhibition of DNA repair.
    Gangopadhyay S; Karmakar P; Dasgupta U; Chakraborty A
    Mutat Res; 2007 Oct; 633(2):117-25. PubMed ID: 17627868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytotoxicity of antitumor platinum complexes with L-buthionine-(R,S)-sulfoximine and/or etanidazole in human carcinoma cell lines sensitive and resistant to cisplatin.
    Brooks SE; Korbut TT; Dupuis NP; Holden SA; Teicher BA
    Cancer Chemother Pharmacol; 1995; 36(5):431-8. PubMed ID: 7634385
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential effect of the calmodulin inhibitor trifluoperazine on cellular accumulation, retention, and cytotoxicity of anthracyclines in doxorubicin (adriamycin)-resistant P388 mouse leukemia cells.
    Ganapathi R; Grabowski D; Rouse W; Riegler F
    Cancer Res; 1984 Nov; 44(11):5056-61. PubMed ID: 6488165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metallothionein gene expression and resistance to cisplatin in human ovarian cancer.
    Schilder RJ; Hall L; Monks A; Handel LM; Fornace AJ; Ozols RF; Fojo AT; Hamilton TC
    Int J Cancer; 1990 Mar; 45(3):416-22. PubMed ID: 2307530
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanisms associated with the expression of cisplatin resistance in a human ovarian tumor cell line following exposure to fractionated X-irradiation in vitro.
    Dempke WC; Shellard SA; Hosking LK; Fichtinger-Schepman AM; Hill BT
    Carcinogenesis; 1992 Jul; 13(7):1209-15. PubMed ID: 1638688
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Revertant and potentiating activity of lonidamine in patients with ovarian cancer previously treated with platinum.
    De Lena M; Lorusso V; Bottalico C; Brandi M; De Mitrio A; Catino A; Guida M; Latorre A; Leone B; Vallejo C; Gargano G
    J Clin Oncol; 1997 Oct; 15(10):3208-13. PubMed ID: 9336357
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhanced cisplatin cytotoxicity by disturbing the nucleotide excision repair pathway in ovarian cancer cell lines.
    Selvakumaran M; Pisarcik DA; Bao R; Yeung AT; Hamilton TC
    Cancer Res; 2003 Mar; 63(6):1311-6. PubMed ID: 12649192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlation of the response to cisplatin of human ovarian cancer cell lines, originating from one tumor but with different sensitivity, with the recovery of DNA adducts.
    De Pooter CM; Van Oosterom AT; Scalliet PG; Maes RA; de Bruijn EA
    Biochem Pharmacol; 1996 Mar; 51(5):629-34. PubMed ID: 8615899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of the mitogen-activated protein kinase kinase/extracellular signal-regulated kinase pathway overcomes cisplatin resistance in ovarian carcinoma cells.
    Nonaka M; Itamochi H; Kawaguchi W; Kudoh A; Sato S; Uegaki K; Naniwa J; Sato S; Shimada M; Oishi T; Terakawa N; Kigawa J; Harada T
    Int J Gynecol Cancer; 2012 Jul; 22(6):922-9. PubMed ID: 22672985
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tubeimoside I sensitizes cisplatin in cisplatin-resistant human ovarian cancer cells (A2780/DDP) through down-regulation of ERK and up-regulation of p38 signaling pathways.
    Liu HZ; Yu C; Yang Z; He JL; Chen WJ; Yin J; Li WM; Liu HT; Wang YX
    Mol Med Rep; 2011; 4(5):985-92. PubMed ID: 21687949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Arabinosyl-2-fluoroadenine augments cisplatin cytotoxicity and inhibits cisplatin-DNA cross-link repair.
    Yang LY; Li L; Keating MJ; Plunkett W
    Mol Pharmacol; 1995 May; 47(5):1072-9. PubMed ID: 7746274
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effect of calmodulin antagonist on chemosensitivity of primary cultured lung cancer cells].
    Xiong W; Shen H
    Zhonghua Zhong Liu Za Zhi; 1995 Sep; 17(5):347-9. PubMed ID: 8697972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of carrier ligand in platinum resistance of human carcinoma cell lines.
    Schmidt W; Chaney SG
    Cancer Res; 1993 Feb; 53(4):799-805. PubMed ID: 8428361
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene expression in X-irradiated human tumour cell lines expressing cisplatin resistance and altered DNA repair capacity.
    Taverna P; Hansson J; Scanlon KJ; Hill BT
    Carcinogenesis; 1994 Sep; 15(9):2053-6. PubMed ID: 7923602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enhanced antitumor activity of irofulven in combination with 5-fluorouracil and cisplatin in human colon and ovarian carcinoma cells.
    Poindessous V; Koeppel F; Raymond E; Cvitkovic E; Waters SJ; Larsen AK
    Int J Oncol; 2003 Nov; 23(5):1347-55. PubMed ID: 14532976
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative cytotoxicity of CI-973, cisplatin, carboplatin and tetraplatin in human ovarian carcinoma cell lines.
    Perez RP; O'Dwyer PJ; Handel LM; Ozols RF; Hamilton TC
    Int J Cancer; 1991 May; 48(2):265-9. PubMed ID: 2019469
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Trifluoperazine, a Well-Known Antipsychotic, Inhibits Glioblastoma Invasion by Binding to Calmodulin and Disinhibiting Calcium Release Channel IP3R.
    Kang S; Hong J; Lee JM; Moon HE; Jeon B; Choi J; Yoon NA; Paek SH; Roh EJ; Lee CJ; Kang SS
    Mol Cancer Ther; 2017 Jan; 16(1):217-227. PubMed ID: 28062709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.